| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| IONIS PHARMACEUTICALS INC | EVP, Chief Development Officer | Common Stock | 14,718 | $1,113,563 | $75.66 | 16 Jan 2026 | Direct |
| IONIS PHARMACEUTICALS INC | EVP, Chief Development Officer | Restricted Stock Unit | 45,730 | 15 Jan 2026 | Direct | ||
| IONIS PHARMACEUTICALS INC | EVP, Chief Development Officer | Non-Qualified Stock Option (right to buy) | 16,600 | 02 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| IONS | IONIS PHARMACEUTICALS INC | 15 Jan 2026 | 5 | -$313,308 | 4 | EVP, Chief Development Officer | 20 Jan 2026, 20:18 |
| IONS | IONIS PHARMACEUTICALS INC | 02 Jan 2026 | 1 | $0 | 4/A | EVP, Chief Development Officer | 20 Jan 2026, 20:20 |
| IONS | IONIS PHARMACEUTICALS INC | 21 Dec 2025 | 0 | $0 | 3 | EVP, Chief Development Officer | 06 Jan 2026, 17:34 |